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Abstract
This proof-of-concept study aimed to assess the ability of a mobile application and cloud analytics software solution to
extract facial expression information from participant selfie videos. This is one component of a solution aimed at
extracting possible health outcome measures based on expression, voice acoustics and speech sentiment from video diary
data provided by patients. Forty healthy volunteers viewed 21 validated images from the International Affective Picture
System database through a mobile app which simultaneously captured video footage of their face using the selfie camera.
Images were intended to be associated with the following emotional responses: anger, disgust, sadness, contempt, fear,
surprise and happiness. Both valence and arousal scores estimated from the video footage associated with each image were
adequate predictors of the IAPS image scores (p < 0.001 and p = 0.04 respectively). 12.2% of images were categorised as
containing a positive expression response in line with the target expression; with happiness and sadness responses
providing the greatest frequency of responders: 41.0% and 21.4% respectively. 71.2% of images were associated with
no change in expression. This proof-of-concept study provides early encouraging findings that changes in facial expres-
sion can be detected when they exist. Combined with voice acoustical measures and speech sentiment analysis, this may
lead to novel measures of health status in patients using a video diary in indications including depression, schizophrenia,
autism spectrum disorder and PTSD amongst other conditions.
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Introduction
Mental health disorders are among the most common health
conditions affecting the adult population [1]. Anxiety and de-
pressive disorders are estimated to affect over 322 million and
264 million people worldwide respectively [2]. The Global
Burden of Disease Study 2017 estimated that depressive dis-
orders were the third highest cause of years lived with disabil-
ity (YLD) globally [3]. Over 50% of the general population in
middle- and high-income countries are estimated to suffer
from at least one mental health disorder in their lifetimes [4] .
In the EU, it is estimated that each year almost 40% of the
population suffer from some form of mental health condition
[5], with anxiety disorders affecting around 14% of the popu-
lation, and insomnia and major depressive disorders the next
highest affecting 7% and 6.9% respectively [5]. In England
the prevalence of mental health disorders is predicted to rise
by 14.2% over the 20-year period from 2007 to 2026 [6].
Spending in health and social care related to mental health in
England is estimated to account for around 12% of the
National Health Service budget and cost approximately
US$28 billion a year [6].
With high and increasing global prevalence of mental
health disorders, there is a need to evaluate the progress of
patients in effective and efficient ways both in routine care and
to assess intervention effects in clinical research.
Speech patterns, and their changes over time, provide po-
tential insights into the health status of patients. For example,
a study of patients with Parkinson’s disease showed that
around 75% of patients exhibit some form of vocal
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impairment [7]; and voice acoustical changes can be good
predictors of early onset of the disease [8]. In patients with
depression, certain aspects of speech, such as speaking rate
and pitch variability, have been shown to correlate well with
conventional measures of the severity of depression such as
the Hamilton Depression Rating Scale [9].
Smartphone technology has simplified the collection of
digital voice samples. For example, phonation tests for
Parkinson’s disease patients have been developed in clinical
research mobile applications (apps) using both Apple
Research Kit [10] and on the Android platform [11]. This
opens the possibility of using such inexpensive techniques in
large-scale clinical trials and within routine care.
More recently, machine learning techniques afford greater
opportunity to derive insights from complex data such as
voice samples. One study, for example, usedmachine learning
techniques to create a model based on an initial input of 370
extracted linguistic features that was able to adequately distin-
guish between Alzheimer’s disease patients and healthy con-
trols based on analysis of short narrative samples elicited with
a picture description task [12].
Similarly, video analysis may provide valuable health
status insights. Depression is often associated with a flat-
tening of positive emotional responses [13] which can be
expressed in blunted expression. Promising work has been
conducted on the extraction of facial expression based on
computer recognition of the relative position of facial land-
marks – for example in aiding the diagnosis of autism
spectrum disorders in young children while watching short
video content designed to elicit certain emotional re-
sponses such as surprise and happiness [14].
Objective measures based on expression and speech in-
dices derived from video diary data may provide additional
insights into the health status of patients suffering from
certain mental health conditions such as depression, anxi-
ety, schizophrenia, autism spectrum disorder, PTSD and
others. Current measurement approaches in clinical trials
typically centre around subjective clinical outcome assess-
ments (COAs) made by the patient individually or by a
clinician during a psychiatric interview. The same mea-
sures are also used to measure disease severity in clinical
practice, for example UK primary care physicians are
funded through the Health Service’s Quality and
Outcomes Framework (QOF) for assessing the severity of
symptoms of depression by using one or a number of self-
and clinician-assessed COAs [15]. In some cases, the sub-
jectivity of these measures may make them less sensitive to
detecting intervention effects. In an analysis of new drug
applications approved by the FDA between 1985 and
1997, for example, Khan et al. [16] reported that over
50% of adequate-dose new antidepressant treatment arms
failed to demonstrate statistically significant separation
from placebo.
Video diary Mobile application (VDMA): An
expression- and speech-tracking mobile platform
It was our intention to create a method of assessing mental
health status that removed subjectivity from the measurement
process and may provide a valuable adjunct or alternative to
current subjective assessments. To this end we developed a
mobile application and cloud analytics software solution to
extract possible health outcome measures based on expres-
sion, voice acoustics and speech sentiment analysis from vid-
eo diary footage collected using an Android smartphone app
(Fig. 1). The app is intended to be used by patients to record
how they feel in their own words longitudinally before, during
and after a treatment intervention. In depression, for example,
patients may be prompted to describe through short videos
how they are feeling emotionally and physically, and how
these feelings impact their daily life. In addition to providing
a good reference to enable self-assessment of change over
time, the analysis of resulting video in terms of expression,
voice acoustics and speech sentiment may lead to composite
endpoints that provide a useful objective measure of health
status and disease severity to enable longitudinal changes to
be tracked and the effects of interventions measured.
For the expression assessment component of the VDMA,
self-recorded video segments collected using the app were
stored and facial expression metrics were extracted for each
video frame using Microsoft Azure® Cognitive Services
(Microsoft Corporation, Redmond,WA, USA). This provided
a frame-by-frame measure of the relative presence of eight
expressions: anger, contempt, disgust, fear, happiness, sad-
ness, surprise and neutral. Frame data was combined to gen-
erate an expression profile which could be inspected and sum-
mary measures extracted. This proof-of-concept study aimed
to obtain preliminary data to assess the validity of this expres-
sion detection component of the VDMA system.
Methods
The first step in demonstrating a proof-of-concept is to con-
firm that the system can accurately identify emotions via a
video recording of participants’ faces. To do this, we need a
ground truth of what participants are feeling at a particular
point in time. While it is possible to ask participants what
emotion they were feeling (which we did), there is no guaran-
tee that self-report is accurate due to lack of introspection and
reporting biases (one of the criticisms of self-evaluations).
Instead we opted to verify the efficacy of the facial encoding
by presenting participants with images from the International
Affective Picture System (IAPS) [17], which are known to
evoke specific emotions in viewers.
To facilitate this, we modified the VDMA to present im-
ages on screen that were intended to evoke an emotional
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response, and simultaneously capture associated facial expres-
sion using video footage recorded using the selfie camera
during image presentation. Healthy volunteers aged between
18 and 65 years, non-pregnant and without heart condition or
any condition or ongoing treatment affecting emotional state,
were requested to view 21 validated images from the IAPS
database [17] (Online Resource 1) with simultaneous capture
of video footage for 5 s following image presentation. Images
were selected to generate the following emotional responses:
anger, disgust, sadness, contempt, fear, surprise and happiness
(3 images for each emotional response). A reset period of 4 s
was applied between each image presented in which a neutral
image was displayed for 3 s, followed by a fixation cross in the
centre of the screen for a duration of 1 s in order to cue the
participant to focus their attention in the centre of the screen.
After each image was presented, participants were also asked
to provide self-ratings of their emotional response associated
with each image using a 10-point numeric response scale to
rate each possible emotion (0 = none, 9 = extremely). The
combined reset period and time taken for self-rating of emo-
tional response was considered more than adequate to avoid
carryover of responses between images. Expression analysis
was performed using Microsoft Azure Cognitive Services
which provided a measure of the estimated relative influence
of each emotion within each frame of the captured video seg-
ment, and the association with IAPS data was assessed for
each image quantitatively and qualitatively.
Eligible participants based in the UK were invited to par-
ticipate in this single centre, single visit study. Participants
provided written informed consent to participate. The study
was approved by the Nottingham Trent University
Independent Ethics Committee, UK.
Emotional response profiles were also summarised into
two measures: valence (unpleasant to pleasant) and arousal
(calm to exciting) ranging from 0 to 9 on a frame-by-frame
basis. Each frame was assigned a dominant emotion deter-
mined as the emotion identified to increase the most from
the previous video frame, and this frame was assigned valence
and arousal scores associated with the dominant emotion
based on the relationships estimated from Lang [18]
(Table 1). Overall valence and arousal scores were calculated
by averaging the per-frame values. This method was selected
with the aim of limiting the influence of resting expressions on
the estimates of valence and arousal responses to the IAPS
images.
Data were analysed quantitatively and qualitatively. In the
quantitative analysis valence and arousal scores were assessed
in their ability to predict the IAPS image valence and arousal
scores using linear mixed-effects multi-level models, control-
ling for random effects using random by-participants and by-
stimulus image intercepts. In the qualitative analysis, each 5 s
Table 1 Valance and
arousal scores assigned
to per-frame dominant
emotions extracted from
video footage recorded
by the VDMA, based on
[18]
Emotion Valance Arousal
Anger 2 8
Contempt 2 8
Disgust 1 8
Fear 3 7
Happiness 8 3
Sadness 1.5 4.5
Surprise 5 8
Neutral 5 0
Fig. 1 The VDMA and
associated cloud analytics
software solution
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expression profile was categorised manually using the follow-
ing categories: a positive response in line with the target ex-
pression, a non-response, or a false-positive response (i.e., an
emotional response was detected, but a different response to
that intended by the specific IAPS image).
The validity of the IAPS images in evoking the intended
emotion in the study sample was evaluated with reference to
the self-assessment scores received for each image.
Results
Forty participants (ages 21–57 years; Sex: M (20), F (19), Not
stated (1)) participated in this proof-of-concept study
(Table 2). One participant was excluded from the analysis as
the video data were unusable due to placing their hands over
their face during most video segments.
Quantitative analysis of valence and arousal
The ordering of mean valence scores estimated by the VDMA
was broadly in line with those provided with the IAPs images
(Table 3). This relationship was less apparent for the arousal
estimates (Table 3). A significant main effect of VMDA va-
lence scores was found when comparing the intercept only
model (Akaike information criterion (AIC) = 22,298), con-
taining only intercepts and random effects to predict the
IAPS valence scores, and an additive model in which
VMDA score was added as a fixed effect (AIC = 22,278, χ2
(1) = 21.93, p < .001). This significant main effect provides
some evidence that the valence scores estimated by the
VMDA predict the mean valence scores associated with the
IAPS images. Similarly, a comparison of the intercept only
model (AIC = 14,554), containing only intercepts and random
effects to predict the IAPS arousal scores, and an additive
model containing the VDMA arousal scores as a fixed effect
(AIC = 14,552), found a significant main effect for VDMA
arousal scores (χ2 (1) = 4.11, p = .04). This also provides some
support that the VDMA arousal scores predict the mean arous-
al scores associated with the IAPS images.
Qualitative analysis of response type
The expression data were hard to summarise via automated
summary measures because (i) some participants exhibited a
resting face expression that was not neutral, and this could
mask the detection of the target expression, (ii) some partici-
pants showed the target expression response, but this was
superimposed by one or more other dominant expressions,
and (iii) some target expression profiles may be dominated
by a later rebound expression (e.g. happiness following a fear
response). For these reasons, it was determined to categorise
individual image response profiles manually by inspection by
a single reviewer. One additional participant was excluded
from this analysis as they provided only 8/21 video segments.
Each image profile (n = 819 profiles from 39 participants, see
Figs. 2-4) was reviewed qualitatively to assess whether the
target expression could be observed via a peak relative to the
starting expression. Types of response and non-response to
each image was classified into a number of observed patterns:
& Positive responder, where a clear response of the target
expression was dominant for part of the response profile
(Positive-responders, Fig. 2).
& Positive responses with interference from other expression
profiles, including responses saturated by another domi-
nant expression (Positive-saturated, Fig. 3a), responses
mixed with a number of other expressions of similar mag-
nitude (Positive-mixed, Fig. 3b) and responses that also
show a rebound of a further (non-target) emotion
(Positive-rebound, Fig. 3c).
& False-positive, an expression detected other than the target
expression.
& Non-responder, where a neutral expression, or no change
in expression was observed (Fig. 4).
Responses in agreement with the target response
100 profiles (12.2%) were categorised as containing a positive
response in expression in line with the target expression
Table 3 IAPS valence and arousal measures and corresponding values
estimated from the VDMA
Emotion Valence (mean [SD]) Arousal (mean [SD])
IAPS VDMA IAPS VDMA
Anger 1.85 [1.28] 3.71 [2.06] 6.89 [2.18] 5.13 [1.30]
Disgust 2.14 [1.38] 3.76 [2.20] 6.54 [2.21] 4.92 [1.18]
Sadness 2.26 [1.50] 3.84 [1.95] 4.37 [2.09] 4.95 [0.97]
Contempt 2.30 [1.76] 3.78 [1.99] 6.21 [2.36] 4.91 [0.93]
Fear 3.63 [1.86] 3.84 [2.08] 6.69 [1.88] 4.85 [0.95]
Surprise 6.67 [1.82] 4.32 [2.13] 6.26 [2.11] 4.74 [0.96]
Happiness 7.71 [1.43] 5.55 [2.40] 4.45 [2.24] 4.25 [1.29]
Table 2 Participant
characteristics Variable N = 40
Age (years)
Range 21–57
Mean [SD] 30.9 [10.3]
Gender
Female 19
Male 20
Not stated 1
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(Table 4). Of these, target images expected to elicit responses of
happiness and sadness provided the highest frequency of re-
sponders: 48 and 25 positive responses representing success
rates of 41.0% and 21.4% respectively. Relatively few positive
responses were observed in response to images targeting ex-
pressions of anger, contempt, disgust, fear and surprise.
Fig. 2 Representative positive responder profiles
Fig. 3 Representative positive responder profiles with mixed profiles
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Non-responders and false positive responses
719 profiles (87.8%) were categorised as containing a non-
response relative to the target image, with 18.3% to 30.3% of
these showing false positive responses in favour of a non-
target expression for all expressions except happiness and
sadness (Table 4). For these emotions, few false-positives
were observed amongst the non-responders: 4 (5.8%) and 7
(7.6%) for happiness and sadness respectively.
Detection of any change in facial expression
We further categorised each participant in terms of their ability
to present a change of expression in response to the images
presented. 9/39 (23%) we identified as responders, having at
least 5/21 responses in line with the target expression of the
images presented (Table 5). Of these, 7 participants we
categorised as expressive responders, those that provided a
high number of false positives in addition to responses in line
with the target expression. Amongst the non-responders, 29
(74.4%) of participants provided 0–3 positive responses to the
target expression.
Association between self-rated emotion and IAPS
target emotions
Descriptive analysis of the self-rated emotion associated with
each image provided by the participants showed that overall,
Table 4 Proportions of responders and non-responders from categorisation of expression response profile by IAPS image type
Expression Category Target Emotion (n)
Anger Contempt Disgust Fear Happiness Sadness Surprise TOTAL
Responder 6 8 8 3 48 25 2 100
Positive responder 3 (50%) 5 (62.5%) – – 44 (91.7%) 22 (88%) – 74 (74%)
Positive-saturated 1 (16.7%) 2 (25%) 5 (62.5%) – 2 (4.2%) – 1 (50%) 11 (11%)
Positive-mixed 2 (33.3%) 1 (12.5%) 3 (37.5%) 2 (66.7%) 2 (4.2%) 2 (12%) – 12 (12%)
Positive-rebound – – – 1 (33.3%) – – 1 (50%) 2 (2%)
Non-responder 111 109 109 114 69 92 115 719
False positive 25 (22.5%) 24 (22%) 33 (30.3%) 22 (19.3%) 4 (5.8%) 7 (7.6%) 21 (18.3%) 136 (18.9%)
Non-responder 86 (77.5%) 85 (78%) 76 (69.7%) 92 (80.7%) 65 (94.2%) 85 (92.4%) 94 (81.7%) 583 (81.1%)
Fig. 4 Representative non-responder (a, b) and false positive (c) profiles
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640/819 (78.1%) of IAPS images were self-rated with the
target emotion ranked top or second, with rates for emotion-
specific images of 59.8%, 63.3%, 82.1%, 76.9%, 95.7%,
96.6% and 72.7% for anger, contempt, disgust, fear, happi-
ness, sadness and surprise respectively (Fig. 5).
Conclusions and discussion
Good correspondence of the IAPS-designated target emotion
with the self-ratings of participants provides some confidence
that the images used to target emotional responses in these
participants were appropriate despite known concerns regard-
ing self-report measures noted above.
Almost 30% of the images presented (236/819, 28.8%)
were associated with detecting an emotional response, with
almost half of these (100/819, 12.2%) associated with a pos-
itive response in line with the target expression. Positive re-
sponses were more common in association with images
intended to evoke happiness and sadness (41% and 21.4%
positive response rates respectively).
However, the majority of images resulted in no response
by the participants. 583/819 (71.2%) of images were asso-
ciated with neither a positive nor a false-positive response.
Inspection of the video footage showed that in these cases
facial expression following exposure to an image did not
change throughout the subsequent 5-s interval. A 5-s inter-
val was considered adequate to evoke a change in facial
expression as macro expressions of emotion covering large
areas of the face can typically take up to 2 s to be expressed
[19], and another study exploring emotion elicitation using
video and photographic stimuli used a similar time interval
(6 s) in which to study response [20]. We believe the non-
response rate observed to be a limitation of the experiment
as opposed to a failure to support the concept of extraction
of expression artefacts from video diary footage. In our
experiment, we have assumed that the emotions evoked
by viewing an image may be externalised by a change in
facial expression. One reason for low emotion-expression
coherence may be insufficient intensity of the underlying
emotion to evoke an external response [21]. In addition,
some facial expressions of emotions are more prone to
expression in social as opposed to solitary contexts [21].
In our experiment there may be a “white coat effect”
resulting in participants being less relaxed in the experi-
mental conditions as they might be in a normal conversa-
tional situation, meaning they are less able to represent
natural expressions and changes in expression in response
to image presentation. In addition, participants may exhibit
an element of immunity to the impact of screen-based im-
ages due to the likely amount of time participants spend
being exposed to a variety of images through television
and social media.
Despite this, the objective of this proof of concept study
was to examine the ability of the VDMA solution to measure
changes in facial expression, where they exist. This proof-of-
concept study provides early encouraging findings that facial
expressions derived from video footage may provide appro-
priate measures of expression. The non-response rate is likely
a limitation of the experiment, and expression detection may
be more sensitive in conversational settings and when looking
at within-individual changes over time. The VDMA is
Fig. 5 Comparison of emotion
self-rating vs. IAPS category for
each image used
Table 5 Distribution of overall responder types of the participants (n =
39)
Responder type N = 39
Responder 2 (5.1%)
Responder (expressive) 7 (17.9%)
Non-responder 29 (74.4%)
Non-responder (expressive) 1 (2.6%)
Responder = 5–6 positive responses out of 21 IAPS images; Responder
(expressive) = 5–9 positive responses and 5–10 false positives; Non-re-
sponder = 0–3 positive responses out of 21 IAPS images; Non-responder
(expressive) = 4 positive responses and 8 false positives
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expected to operate as a video diary in which patients are
requested to record how they feel in their own words lon-
gitudinally before and during a treatment intervention. In
depression, for example, patients may describe in their
own words through short videos how they are feeling emo-
tionally and physically, and how these feelings impact their
daily life. The non-verbal aspects of this communication
may be as informative as the words used themselves, and
patients or a caring physician reviewing these video re-
cords may pick up on these cues in addition to the infor-
mational content delivered to aid their interpretation of
patient health status. The MERET instrument, for example,
has demonstrated utility in enhancing patients’ overall im-
pression of change in health status through self-review of
audio recorded self-assessments made before treatment in-
tervention in patients with major depressive disorder [22].
As a next step we intend to evaluate the sensitivity of facial
expression detection in the context of a conversational vid-
eo diary in patients suffering from depression. When ex-
pression analysis is combined with voice and sentiment
analysis, this may lead to novel automated measures of
health status in patients using a video diary in indications
including depression, anxiety, schizophrenia, autism spec-
trum disorder, PTSD and others.
The utility of this approach may provide valuable objective
endpoints to contribute to the measurement of intervention
effects in pharmaceutical clinical trials. It may also enable
objective measures that can be presented alongside a video
diary review interface to enable enhanced assessment and
monitoring of patients by physicians during routine care for
various mental health conditions.
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